These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
31. Clinical and pathological findings in familial amyloid polyneuropathy caused by a transthyretin E61K mutation. Murakami T; Nishimura H; Nagai T; Hemmi S; Kutoku Y; Ohsawa Y; Sunada Y J Neurol Sci; 2017 Oct; 381():55-58. PubMed ID: 28991715 [TBL] [Abstract][Full Text] [Related]
32. Effect of age and sex differences on wild-type transthyretin amyloid formation in familial amyloidotic polyneuropathy: a proteomic approach. Tasaki M; Ueda M; Obayashi K; Koike H; Kitagawa K; Ogi Y; Jono H; Su Y; Suenaga G; Oshima T; Misumi Y; Yoshida M; Yamashita T; Sobue G; Ando Y Int J Cardiol; 2013 Dec; 170(1):69-74. PubMed ID: 24182678 [TBL] [Abstract][Full Text] [Related]
33. Familial transthyretin-type amyloid polyneuropathy in Japan: clinical and genetic heterogeneity. Ikeda S; Nakazato M; Ando Y; Sobue G Neurology; 2002 Apr; 58(7):1001-7. PubMed ID: 11940682 [TBL] [Abstract][Full Text] [Related]
34. Clinical picture and outcome of transthyretin-related familial amyloid polyneuropathy (FAP) in Japanese patients. Ikeda S Clin Chem Lab Med; 2002 Dec; 40(12):1257-61. PubMed ID: 12553427 [TBL] [Abstract][Full Text] [Related]
35. A low amyloidogenic E61K transthyretin mutation may cause familial amyloid polyneuropathy. Murakami T; Yokoyama T; Mizuguchi M; Toné S; Takaku S; Sango K; Nishimura H; Watabe K; Sunada Y J Neurochem; 2021 Mar; 156(6):957-966. PubMed ID: 32852783 [TBL] [Abstract][Full Text] [Related]
37. Effect of albumin on transthyretin and amyloidogenic transthyretin Val30Met disposition and tissue deposition in familial amyloidotic polyneuropathy. Taguchi K; Jono H; Kugimiya-Taguchi T; Nagao S; Su Y; Yamasaki K; Mizuguchi M; Maruyama T; Ando Y; Otagiri M Life Sci; 2013 Dec; 93(25-26):1017-22. PubMed ID: 24211615 [TBL] [Abstract][Full Text] [Related]